<DOC>
	<DOCNO>NCT00975494</DOCNO>
	<brief_summary>In heart failure ( HF ) , defective nitric oxide ( NO ) signal may involve leave ventricular ( LV ) diastolic abnormality LV remodelling progression . PDE5-inhibition , block NO degradation overexpressing cellular cyclic guanosine monophosphate ( cGMP ) pathway might beneficial . Several short term study demonstrate safety clinical improvement stable heart failure ( HF ) patient . The purpose study test effect LV diastolic function , cardiac geometry clinical status cohort HF patient .</brief_summary>
	<brief_title>Chronic Sildenafil Treatment Heart Failure</brief_title>
	<detailed_description>Heart failure ( HF ) significant health care concern evolve epidemic proportion . Development new form intervention remain challenge task . An abnormal nitric oxide ( NO ) pathway involved several basic pathophysiological abnormality encounter HF syndrome NO overexpression may represent desirable therapeutic target cure disease . PDE5-inhibition intriguing pharmacological strategy enhance vivo nitric oxide ( NO ) signal increase cyclic guanosine monophosphate ( cGMP ) . availability . A number theoretical background support use PDE5-inhibitors HF increase number clinical study test PDE5-inhibition potential valid adjunct management HF patient . In fail heart animal model , PDE5-inhibition also provide attractive therapeutic property reverse leave ventricular chamber remodelling prevent reverse LV cardiac hypertrophy fibrosis protect myocardium ischemia-reperfusion injury apoptosis . There also evidence defective NO activity play important role excitation-relaxation process fail heart , effect explain defective cGMP-induced phosphorylation troponin I , facilitate calcium-independent diastolic cross-bridge cycling concomitant myocardium diastolic stiffening . No report far investigate whether cardiac function , primarily , diastolic LV function may target chronic PDE5-inhibition whether improvement diastolic function relate reverse effect cardiac geometry patient HF . Furthermore , undefined whether favourable effect leave ventricular function may involve report change important clinical correlate functional status quality life . We test hypothesis , address effect chronic sildenafil administration ( 50 mg three times/day ) diastolic function clinical status Tissue Doppler imaging , cardiopulmonary exercise test quality life score .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>consent participate study detail information procedure , possible clinical benefit risk ; negative exercise stress test prior study initiation ; force expiratory volume 1 sec/forced vital capacity ratio &gt; 70 % ; left ventricular ejection fraction &lt; 45 % , determine echocardiography . subject unable complete maximal exercise test systolic blood pressure &gt; 140 &lt; 110 mmHg diabetes mellitus therapy nitrate preparation history sildenafil intolerance significant lung valvular disease neuromuscular disorder , claudication peripheral vascular disease</criteria>
	<gender>Male</gender>
	<minimum_age>38 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>pde5-inhibition</keyword>
	<keyword>sildenafil</keyword>
	<keyword>LV diastolic function</keyword>
	<keyword>heart failure patient</keyword>
</DOC>